Overview

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

Status:
Completed

Trial end date:
2015-04-01

Target enrollment:

Participant gender:

Summary

An Open-label, Fixed-sequence, Crossover Study to Evaluate the Pharmacokinetic Interaction and Safety after multiple oral doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd

Collaborator:

Inje University

Treatments:

Amlodipine
Rosuvastatin Calcium